FDA Inspection
Pharmacia & Upjohn Company LLCPharmacia & Upjohn Company LLC – FDA Inspection, Nov 7, 2017
Record Details
This FDA Inspection record concerns Pharmacia & Upjohn Company LLC, with an inspection on November 7, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · bfd7e3c2-6ea5-4ea1-8e3e-220c2ffb8063
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031063
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Pharmacia & Upjohn Company LLC
17| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2026 | Not classified | Detroit District Office | Blood and Blood Products |
| June 16, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 20, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 10, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Pharmacia & Upjohn Company LLC
- FDA Inspection 1295014 - 2026-09-29
- FDA Inspection 1208260 - 2023-06-16
- FDA Inspection 1143004 - 2021-05-20
- FDA Inspection 1074087 - 2018-12-10
- FDA Inspection 1066512 - 2018-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.